23 results
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
BEAM-301 Potential: Correct liver G6PC mutation to restore enzyme activity and enable normal glucose homeostasis, as well as eliminate chronic
8-K
EX-99.1
bodv88ww k7o
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
qkkxrdko
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.1
jreg6zvcnrwvg 0ur
8 Nov 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results
6:19am
10-K
dfb5x1
30 Mar 20
Annual report
5:26pm
424B4
qdjbbt se
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
da37qsyt ds3eei4faj7
17 Jan 20
IPO registration (amended)
4:09pm